Welcome to the Reimbursement Bulletin!
In order to more easily view the new format of this Bulletin, we recommend you view it in your web browser. At the very top it says, "To view this bulletin in a web browser, click here." By viewing it this way, you eliminate the need to go back and forth between your email and web browser, making it much easier to navigate. We hope this helps you enjoy our updated Bulletin!
This Bulletin will be published semi-monthly. As always, any comments, suggestions, stories or questions can be sent to billing@msho.org. We hope you enjoy this issue!
AstraZeneca's New FDA ApprovalUS FDA approves IMFINZI® (durvalumab) for unresectable Stage III non-small cell lung cancer. Details >~ U.S. to cover advanced genomic testing for Medicare cancer patients
~ ASTRO Issues Clinical Guideline For Whole Breast Radiation Therapy Details >
The handout is available on the MSHO Website!Details >Wednesday, April 25, 2018, 8:00 am - 3:30 pmLansing Community College - West Campus Details >
March 2018Including...
~ March 19 UPDATE on the IMPORTANT Changes in the NATIONAL COVERAGE DETERMINATION 110.21 -ERYTHROPOESIS STIMULATING AGENTS Details >Check out these upcoming training events....Including....
~ 4/3 - New to Medicare; Medical Review Details >
Region 1 - Performant Recovery, Inc.March 2018 Details >This edition includes articles on......~ Medicare and Medicaid RAC Audits: How Auditors Get It Wrong Details >Recent Oncology Related Articles~ Quarterly HCPCS Drug/Biological Code Changes MLN Matters Article
~ Medicare Pharmaceutical and Technology Ombudsman
~ New Medicare Card Transition Begins In Less Than a Month
~ New Medicare Card Project Special Open Door Forum — March 20
~ April 2018 Update of the Hospital OPPS MLN Matters Article
~ Provider Compliance Tips for Laboratory Tests: Other Fact Sheet
~ Provider Compliance Tips for Ordering Hospital Outpatient Services Fact Sheet
Details >
Recent Oncology Related News~ Blue Cross to update ClaimsXten with additional professional and outpatient facility edits in June
~ Effective immediately, two CAR T-cell therapies require authorization for Medicare Advantage members
~ Most immune globulin infusions will not be covered at outpatient hospital facilities starting April 1, 2018 Details >
Last Updated 03/20/18Review the reported payer reimbursement issues MSHO is currently addressing... Details >Recent Oncology Related Issues and NewsWE NEED YOUR HELP - ALERT - Thank You, Pending Issue including CPT 96377, MSA Bulletins, Biller "B" Aware Notices Details >~ Aetna OfficeLink Updates
~ BCN Provider News
~ Cigna
~ HAP/HealthPlus ProviderPlus
~ Humana YourPractice
~ UHC NetworkBulletin
~ UHC Medical Policy Update
Details >Featuring this month: Anthem Blue Cross Blue ShieldDetails >
~ Proposed Reforms To The 340B Drug Discount Program Details >
March 2018, Frequently Asked QuestionsTopics Include: Hydration, Therapeutic Infusion, Orders, Concurrent Infusion and more... Details > |
